Appili Therapeutics Inc. (TSX:APLI)
0.0200
-0.0050 (-25.00%)
Apr 28, 2026, 2:36 PM EST
Appili Therapeutics Employees
Appili Therapeutics had 7 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
29.47K CAD
Profits / Employee
-423.37K CAD
Market Cap
2.65M
Employees Chart
Appili Therapeutics News
- 4 weeks ago - Appili Therapeutics to Exhibit at World Vaccine Congress Washington - GlobeNewsWire
- 2 months ago - Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement - GlobeNewsWire
- 2 months ago - Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026 - GlobeNewsWire
- 5 months ago - Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026 - GlobeNewsWire
- 6 months ago - Appili Therapeutics to Attend BARDA Innovation Symposium 2025 - GlobeNewsWire
- 7 months ago - Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01 - GlobeNewsWire
- 7 months ago - Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders - GlobeNewsWire
- 8 months ago - Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference - GlobeNewsWire